Public Health Laboratory Network Publications

---

COVID-19 Publications

Resources published on our new website:

• CDGN, PHLN and CDNA Sampling Strategy for SARS-CoV-2 Genomic Surveillance
• PHLN statement on reporting of SARS-CoV-2 variants of concern and interest
• PHLN statement on asymptomatic testing for SARS-CoV-2
• PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19)
• PHLN evidence review on the utility of COVID-19 testing to reduce the 14-day quarantine period
• PHLN guidance on nucleic acid test result interpretation for SARS-CoV-2
• PHLN statement on use of saliva as an alternative specimen for the diagnosis of SARS-COV-2
• PHLN statement on point-of-care serology testing for SARS-CoV-2 (the virus that causes COVID-19)
• PHLN Recommendations for Non-PHLN Laboratories Undertaking Testing for SARS-CoV-2 (the virus that causes COVID-19)
• PHLN statement on the prioritisation of diagnostic testing for COVID-19
• PHLN and CDNA joint statement on SARS-CoV-2 rapid antigen tests
• CDNA and PHLN joint statement – Revised Australian criteria for the release of persons recovered from COVID-19 from isolation

External resources:

• Sample Pooling is a Viable Strategy for SARS-CoV-2 Detection in Low-Prevalence Settings – article by the Doherty Institute – 2 September 2020

---

General PHLN Publications

• Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia
• Laboratory precautions for samples collected from patients with suspected viral haemorrhagic fevers
• National High Security Quarantine Laboratory Guideline for Management of Quarantinable Viral Haemorrhagic Fevers
• Newsletters
• Policy on antiviral prophylaxis and the implications for pathology and research staff
• PHLN Guidance and Survey regarding Mycobacterium chimaera & heater-cooler units
• PHLN Position Paper on Hendra Specimens for Transport within Australia
• Referral of pneumococcal PCR positive samples to Australian Pneumococcal Reference Laboratories for molecular serotyping